GLAXOSMITHKLINE PHARMA A/S: Financial statements 2021
CVR: 27394019
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
GLAXOSMITHKLINE PHARMA A/S (CVR 27394019) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 445,873,000 and a net result of DKK 8,984,000 compared with DKK 12,271,000 the year before. That is an increase of 0.9% compared with the year before. The profit margin was 2%. Equity in the 2021 report amounted to DKK 34,778,000. The solvency ratio was 25.3%. The company had 66 employees in the financial year.
- Revenue
- DKK 445,873,000
- Gross Profit
- DKK 111,627,000
- Profit/Loss
- DKK 8,984,000
- Equity
- DKK 34,778,000
- Total Assets
- DKK 137,489,000
- Employees
- 66
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 445.9M | 111.6M | 9M | 34.8M | 66 |
| 2020 | 441.7M | 120.3M | 12.3M | 37.8M | 62 |
| 2019 | 417.4M | 114.3M | 11.1M | 35.5M | 68 |
| 2018 | 413.8M | 116.3M | 17.5M | 39.4M | 80 |
| 2017 | 426.9M | 124.4M | 9.6M | 35.4M | 87 |
Official annual report
Find more companies like GLAXOSMITHKLINE PHARMA A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2020. Revenue came to DKK 441,702,000, and the net result was DKK 12,271,000.
About GLAXOSMITHKLINE PHARMA A/S
GLAXOSMITHKLINE PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1968. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named GLAXO DANMARK A/S and GLAXO WELLCOME A/S. The management consists of Diederik Maarten Eijsvogel. The board consists of Luciano Alves de Andrade (chair), Alastair William Jones, Diederik Maarten Eijsvogel and Helle Ann Hellberg. The company is owned by Setfirst Limited. The company has 83 employees (2026). In 2025, the company reported revenue of DKK 580,769,000 and a net result of DKK 13,123,000 compared with DKK 12,240,000 the year before. Equity in the 2025 report amounted to DKK 39,017,000.